Ilan Oren

Ilan Oren is a seasoned executive with extensive experience in the life sciences sector. Currently serving as Chairman of the Board and a Board Member at Roivant Sciences since 2014, Ilan Oren has also held key leadership positions at Dexcel Pharma as Co-Chief Executive Officer and VP of Business Development since 2011. Additional board memberships include Clexio Biosciences, Kriya Therapeutics, and 8400 - The Health Network. Previously, Ilan Oren contributed to Axovant Gene Therapies, Ltd and Cynapsus Therapeutics as a Board Member. Early career experience includes a consulting role at L.E.K. Consulting within the Life Sciences Practice. Ilan Oren is an alumnus of Harvard University, where an AB in Economics was earned.